Skip to main content
. 2021 Feb 26;22:72. doi: 10.1186/s12931-021-01635-w

Fig. 1.

Fig. 1

Prevalence of positive IgA/IgG against Chlamydia pneumoniae (upper panel) and IgM/IgG against Mycoplasma pneumoniae (lower panel)